Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery: The RELIEF Trial

大型腹部手术中的限制性液体治疗与自由性液体治疗：RELIEF 试验

• 批准号: nhmrc : 1043755
• 负责人: Prof Andrew Forbes
• 金额: $ 165.22万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/restrictive-versus-liberal-relief-trial/111599
• 关键词: Restrictive; versus; Liberal; Fluid; Therapy

Major surgery can result in serious complications, some of which lead to permanent disability and early death. All patients undergoing major surgery require intravenous fluids to maintain a healthy circulation, but too much fluid can cause tissue swelling (oedema) and "drown" the vital organs. There are probable benefits of a restrictive IV fluid regimen. This could have major benefits to patients having surgery.

大手术可能会导致严重的并发症，其中一些会导致永久性残疾和过早死亡。所有接受大手术的患者都需要静脉输液以维持健康的循环，但过多的液体会导致组织肿胀（水肿）并“淹没”重要器官。限制性静脉输液方案可能有好处。这可能会给接受手术的患者带来重大好处。